Skip to main content
Premium Trial:

Request an Annual Quote

BGI, Ethiopian Biotechnology Institute to Collaborate on Genomics Research

NEW YORK (GenomeWeb) – BGI and the Ethiopian Biotechnology Institute (EBTi) said yesterday that they have signed a memorandum of understanding on collaborating in genomics and biotechnology.

The document, signed by BGI Chief Development Officer Ning Li and EBTi Director General Kassahun Tesfaye, establishes a framework for a strategic partnership that aims to develop genomics infrastructure in Ethiopia.

Specifically, the partners plan to share information about joint R&D activities and establish research facilities and laboratory infrastructure.

Ethiopia harbors many endemic species and has rich biological diversity. "The EBTi is therefore excited to formalize this partnership with BGI in order to help facilitate critical genomics research in Ethiopia to unlock this potential," Tesfaye said in a statement.

The partnership will enable EBTi to address challenges to genomic research in the country, including ill-equipped facilities, poor accessibility to research centers, and lack of local expertise, Matt Poulter, BGI's business development director for Africa, said in a statement.

EBTi was established by the Ethiopian government in 2016 to conduct biotechnology R&D in the country.

 

The Scan

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.